Wednesday 5 May 2021
Home      All news      Contact us      RSS      Chinese
asiaone - 14 days ago

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirementsGlobeNewswireApril 21, 2021RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions. With more than 25 years of experience executing comprehensive pharmacovigilance and patient safety services in all key therapeutic areas including infectious diseases, PRA can work closely with drug developers and manufacturers in ensuring long-term safety and efficacy of COVID-19 vaccines and treatments.


Latest News
Hashtags:   

Health

 | 

Sciences

 | 

expands

 | 

response

 | 

COVID

 | 

pharmacovigilance

 | 

solutions

 | 

authorized

 | 

vaccines

 | 

therapeutics

 | 

Sources